World's Best Scientists 2026 revealed!
Pierluigi Paggiaro

Pierluigi Paggiaro

D-Index & Metrics

Microbiology

D-Index
63
Citations
16781
World Ranking
2701
National Ranking
65

Pierluigi Paggiaro publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Pierluigi Paggiaro sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 384 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Pierluigi Paggiaro D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Pierluigi Paggiaro sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 63 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Pierluigi Paggiaro is affiliated with the University of Pisa in Italy and conducts research primarily in the field of Medicine. Their work focuses on several subfields including Pulmonary and Respiratory Medicine, Physiology, Immunology and Allergy, and Surgery.

The following main topics characterize their research contributions:

  • Asthma and respiratory diseases
  • Respiratory and Cough-Related Research
  • Allergic Rhinitis and Sensitization
  • Eosinophilic Esophagitis
  • Inhalation and Respiratory Drug Delivery
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • IL-33, ST2, and ILC Pathways

Among recent papers with significant citations are:

  • Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis (2022), published in The Journal of Allergy and Clinical Immunology In Practice
  • Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry (2020), published in Respiratory Medicine
  • Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management (2022), published in Expert Review of Respiratory Medicine
  • Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI (2021), published in Allergy Asthma and Immunology Research
  • Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study (2022), published in The Lancet Respiratory Medicine

Frequent coauthors in Pierluigi Paggiaro's publications include:

  • Giorgio Walter Canonica
  • Francesco Blasi
  • Gianenrico Senna
  • Enrico Heffler
  • Manuela Latorre

The scientist's work has been published predominantly in the following venues:

  • Journal of Clinical Medicine
  • The Journal of Allergy and Clinical Immunology In Practice
  • World Allergy Organization Journal
  • Therapeutic Advances in Respiratory Disease
  • Respiratory Medicine

Best Publications

  • Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

    Claus Bachert;Claus Bachert;Joseph K Han;Martin Desrosiers;Peter W Hellings

  • A summary of the new GINA strategy: a roadmap to asthma control.

    Helen K. Reddel;Eric D. Bateman;Allan Becker;Louis-Philippe Boulet

  • Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy

    Huib A. M. Kerstjens;Michael Engel;Ronald Dahl;Pierluigi Paggiaro

  • Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease

    Pier Luigi Paggiaro;Ragnar Dahle;Ivan Bakran;Lucy Frith

  • Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

    Nicola A Hanania;Phillip Korenblat;Kenneth R Chapman;Kenneth R Chapman;Eric D Bateman

  • Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease

    Salman H. Siddiqui;Alessandro Guasconi;Jørgen Vestbo;Paul Jones

  • Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma

    Alberto Papi;Giorgio W. Canonica;Piero Maestrelli;Pierluigi Paggiaro

  • Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS) : baseline data from a prospective cohort study

    Dirkje S Postma;Chris Brightling;Simonetta Baldi;Maarten Van den Berge

  • Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts

    Stefano Carnevali;Stefano Petruzzelli;Biancamaria Longoni;Renato Vanacore

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view.

    S Saturni;F Bellini;F Braido;Pier Luigi Paggiaro

  • Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK

    P. Demoly;P. Paggiaro;V. Plaza;S. C. Bolge

  • Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.

    Unknown

  • The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions.

    Eva Polverino;Katerina Dimakou;John Hurst;Miguel Angel Martinez-Garcia

  • MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

    Jean Bousquet;Holger J. Schünemann;Peter W. Hellings;Sylvie Arnavielhe

  • ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    J Bousquet;P W Hellings;I Agache;A Bedbrook

  • Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.

    A. Papi;P. L. Paggiaro;G. Nicolini;A. M. Vignola

  • The EMBARC European bronchiectasis registry: Protocol for an international observational study

    James D Chalmers;Stefano Aliberti;Eva Polverino;Montserrat Vendrell

  • Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata)

    M. Chan-Yeung;L. MacLean;P.L. Paggiaro

  • Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials

    Johann Christian Virchow;Piotr Kuna;Pierluigi Paggiaro;Alberto Papi

  • Malondialdehyde in Exhaled Breath Condensate as a Marker of Oxidative Stress in Different Pulmonary Diseases

    M. L. Bartoli;F. Novelli;F. Costa;L. Malagrinò

  • A Randomized Controlled Trial on Office Spirometry in Asthma and COPD in Standard General Practice* Data From Spirometry in Asthma and COPD: a Comparative Evaluation Italian Study†

    Mirco Lusuardi;Fernando De Benedetto;Pierluigi Paggiaro;Claudio M. Sanguinetti

  • Follow‐up study of patients with respiratory disease due to toluene diisocyanate (TDI)

    Pier Luigi Paggiaro;Am Loi;O Rossi;B Ferrante

Frequent Co-Authors

Francesco Blasi
Francesco Blasi University of Milan
Giorgio Walter Canonica
Giorgio Walter Canonica Humanitas University
Alberto Papi
Alberto Papi University of Ferrara
Enrico Heffler
Enrico Heffler Humanitas University
Stefano Bombardieri
Stefano Bombardieri University of Pisa
Gianenrico Senna
Gianenrico Senna University of Verona
Leonardo M. Fabbri
Leonardo M. Fabbri University of Ferrara
Eric D. Bateman
Eric D. Bateman University of Cape Town
Ronald Dahl
Ronald Dahl Aarhus University
Huib A. M. Kerstjens
Huib A. M. Kerstjens University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, exploring related online degrees can open doors to diverse career opportunities in healthcare and research. Fields like health information management are critical in managing patient data and ensuring compliance in medical settings. Programs offering online health information management degree programs cahiim accredited provide quality education aligned with industry standards.

Similarly, pursuing a fast track medical billing and coding certificate online helps students quickly enter the healthcare administration sector, focusing on accurate medical claims processing and billing efficiency.

For those aiming to deepen their medical knowledge, there are options for what medical degree can i get online, which highlight the increasing availability of accredited programs suitable for flexible learning environments.

Public health is another complementary area, where students can benefit from easy mph online programs designed for accessibility without compromising educational quality. Combining microbiology with these pathways strengthens career readiness in a growing healthcare landscape.

Best Scientists Citing Pierluigi Paggiaro

Trending Scientists

Recently Published Articles